⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1372491 | 0.97 | — | — | |
| SCHEMBL28140979 | 0.76 | POLB (0.50) | — | |
| SCHEMBL9637101 | 0.76 | — | — | |
| SCHEMBL12968192 | 0.75 | — | — | |
| SCHEMBL9637052 | 0.75 | — | — | |
| SCHEMBL16793313 | 0.75 | — | — | |
| SCHEMBL3384865 | 0.75 | POLB (0.50) | — | |
| SCHEMBL455088 | 0.73 | — | — | |
| SCHEMBL15571609 | 0.73 | — | — | |
| SCHEMBL15572849 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 986 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025137159-A1 | HUMAN INTERLEUKIN (IL)-17 CYTOKINE BINDING PEPTIDES | PROTAGONIST THERAPEUTICS, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| EP-4541830-A1 | PROCESS FOR PRODUCING POLYURETHANE FOAM | Covestro Deutschland AG (DE) | 2025-04-23 | — | — | EP | claimed |
| CN-116219439-B | Etchant, preparation method and application thereof | 上海盛剑微电子有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-116219439-A | Etchant, preparation method and application thereof | 上海盛剑微电子有限公司 | 2023-06-06 | — | — | CN | claimed |
| EP-4056572-A1 | SYNTHESIS OF SPIROCYCLIC ISOXAZOLINE DERIVATIVES | Zoetis Services LLC (US) | 2022-09-14 | — | — | EP | claimed |
| CN-113548989-A | Preparation process and production line of 4-nitrophenyl-2-methylsulfonyl acetate | 浙江倍合德制药有限公司 | 2021-10-26 | — | — | CN | claimed |
| CN-106588718-A | Preparation method of 2-(methyl sulphonyl)-1-aromatic ethylamine | 杭州新博思生物医药有限公司 | 2017-04-26 | — | — | CN | claimed |
| US-20150291612-A1 | SYNTHESIS OF SPIROCYCLIC ISOXAZOLINE DERIVATIVES | ZOETIS SERVICES LLC | 2015-10-15 | — | — | US | claimed |
| EP-2922854-A1 | SYNTHESIS OF SPIROCYCLIC ISOXAZOLINE DERIVATIVES | Zoetis Services LLC (US) | 2015-09-30 | — | — | EP | claimed |
| CN-104918944-A | Synthesis of spirocyclic isoxazoline derivatives | ZOETIS LLC | 2015-09-16 | — | — | CN | claimed |
| WO-2014081800-A1 | SYNTHESIS OF SPIROCYCLIC ISOXAZOLINE DERIVATIVES | ZOETIS LLC (US) | 2014-05-30 | — | — | WO | claimed |
| US-8002961-B2 | Electrolyte and method of producing the same | ENPIRION, INC. (US) | 2011-08-23 | — | — | US | claimed |
| US-20090065361-A1 | Electrolyte and Method of Producing the Same | INTEL CORPORATION | 2009-03-12 | — | — | US | claimed |
| EP-1870475-B1 | Process for the preparation of optically active amines and amides employing a hydrolase and sulfonyl acetic acid ester as the acyl donor | EVONIK DEGUSSA GMBH (DE) | 2008-12-10 | — | — | EP | claimed |
| EP-4746963-A1 | MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| US-12624028-B2 | 1H-pyrazolo[4,3-G]isoquinoline and 1H-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260103459-A1 | SUBSTITUTED AZACYLES AS TRPM8 MODULATORS | GIVAUDAN SA (CH) | 2026-04-16 | — | — | US | disclosed |
| US-3960855-A | BACTERICIDES | SMITHKLINE CORPORATION (US) | 1976-06-01 | — | — | US | disclosed |
| US-3948905-A | ANTIBACTERIAL | SMITHKLINE CORPORATION (US) | 1976-04-06 | — | — | US | disclosed |
| US-3939266-A | BACTERICIDE | SMITHKLINE CORPORATION (US) | 1976-02-17 | — | — | US | disclosed |